STONEPINE CAPITAL MANAGEMENT, LLC – UroGen Pharma Ltd. Transaction History
STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:
$9.35M
portfolio value
STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+1.59%
quarter
UroGen Pharma Ltd. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +1.19% | 13.17K shares | 255K | $8.32 | 1.12M |
Q2 2022 | share | Increase | +313.29% | 842.21K shares | 6.75M | $8.19 | 1.11M |
Q1 2022 | share | Increase | 0.00% | 268.83K shares | 2.34M | $8.71 | 268.83K |